Asunto(s)
Lesión Renal Aguda/etiología , Betacoronavirus , Infecciones por Coronavirus/complicaciones , Neumonía Viral/complicaciones , Lesión Renal Aguda/complicaciones , Lesión Renal Aguda/diagnóstico , Lesión Renal Aguda/prevención & control , Trastornos de la Coagulación Sanguínea/etiología , COVID-19 , Comunicación , Infecciones por Coronavirus/terapia , Fluidoterapia , Humanos , Hiperpotasemia/etiología , Hiperpotasemia/terapia , Transmisión de Enfermedad Infecciosa de Paciente a Profesional/prevención & control , Pandemias , Planificación de Atención al Paciente , Relaciones Médico-Paciente , Neumonía Viral/terapia , Derivación y Consulta , Terapia de Reemplazo Renal , Factores de Riesgo , SARS-CoV-2RESUMEN
The long-term sequelae of AKI have received increasing attention so that its associations with a number of adverse outcomes, including higher mortality and development of CKD, are now widely appreciated. These associations take on particular importance when considering the high incidence of AKI, with a lack of proven interventions and uncertainties around optimal care provision meaning that the long-term sequelae of AKI present a major unmet clinical need. In this review, we examine the published data that inform our current understanding of long-term outcomes following AKI and discuss potential knowledge gaps, covering long-term mortality, CKD, progression to ESKD, proteinuria, cardiovascular events, recurrent AKI, and hospital readmission.